期刊文献+

重视造血干细胞移植后的病毒感染 被引量:1

Emphasis on viral infection after hematopoietic stem cell transplantation
原文传递
导出
摘要 病毒感染是造血干细胞移植(HSCT)后的常见的并发症。近年来,传统的病毒诊断方法如病毒培养和抗原检测逐渐被聚合酶链反应(PCR)等分子生物学方法所替代。目前移植后病毒感染的诊断主要基于PCR检测抗原核酸。病毒感染可能导致HSCT患者一系列的疾病包括发热、终末器官疾病和恶性肿瘤。疱疹病毒等潜伏病毒的再激活在HSCT后免疫抑制期常见,而呼吸道和肠道病毒等大多为社区获得性病毒。包括抢先治疗在内的预防成功降低了部分病毒感染和疾病的发生率。早期诊断和及时治疗能够改善病毒性疾病的预后。 Viral infections are common complicalions after hematopoietic stem cell transplantation (HSCT). Recently,poly- merase chain reaction (PCR)-based molecular diagnostic methods are rapidly replacing or supplementing the traditional vi- ral diagnostic methods such as viral culture and antigen detection. Nowadays, diagnosis of viral infections relies on polymer- ase chain reaction (PCR)-based methods. Viral infections after allogeneic HSCT result in a spectrum of diseases including fever,end-organ diseases to malignancies. Reactivation of latent viruses, e. g. herpesviruses,is common in the immunosup- pressive recipients. Some viruses such as the respiratory and gastrointestinal viruses are mainly acquired from community. Prophylaxis including preemptive therapy has successfully reduced incidences of some viral diseases. Early diagnosis and timely treatment may significantly improve outcome of viral infections.
作者 林韧 刘启发
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2014年第2期137-141,共5页 Chinese Journal of Practical Internal Medicine
关键词 造血干细胞移植 病毒感染 viral infection hematopoietic stem cell transplantation
  • 相关文献

参考文献1

二级参考文献9

  • 1Gratwohl A, Baldomero H, Horisberger B, et al. Current trends inhematopoietic stem cell transplantation in Europe[ J]. Blood,2002,100:2374 -2386.
  • 2Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation[J].N Engl J Med,1975,292;832 -843.
  • 3Sullivan KM, Witherspoon RP, Storb R, et al. Prednisone and aza-thioprine compared with prednisone and placebo for treatment ofchronic graft versus host disease : prognostic influence of prolongedthrombocytopenia after allogeneic marrow transplantation [ J].Blood, 1988,72:546 -554.
  • 4Kolb HJ. Graft-versus-leukemia effects of transplantation and donorlymphocytes[ J] . Blood,2008 ,112:4371 -4383.
  • 5Pasquini M. Report on state of the art in blood and marrow trans-plantation [C] //America ; Otsuka Pharmaceutical Development &Commercialization,2006,12:5 - 8.
  • 6Martha LA,Amelia Langston,Sagar Lonial. Decreased incidence ofrelapse in patients with acute leukemia transplanted from matchedunrelated donors:induction of GVL[ J]. Blood,2005,106(11) :570.
  • 7Aversa F,Tabilio A, Velardi A, et al. Treatment of high-risk acuteleukemia with T- cell-depleted stem cells from related donors withone fully mismatched HLA haplotype[ J]. N Engl J Med, 1998 ,339 :1186.
  • 8Horowitz MM,Gale RP,Sondel PM,et al. Graft-versus-leukemia reac-tions after bone marrow transplantation [ J]. Blood, 1990,75 :555 -562.
  • 9王健民,章卫平,宋献民,冯曹波,杨建民,陈莉,侯军,周虹,倪雄,高磊,邱慧颖,李红梅,丁晓勤.减低剂量预处理方案对血缘与非血缘关系外周血干细胞移植治疗慢性粒细胞白血病疗效的影响[J].中华血液学杂志,2010,31(2):77-81. 被引量:6

共引文献6

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部